RAIADROGASIL (RADL3) Main Indicators
Company Basic Data| Company | RAIADROGASIL |
| Corporate Name | RAIA DROGASIL S.A. |
| Registration Status | ATIVO |
| Issuer Status | FASE OPERACIONAL |
| Listing Segment | Novo Mercado |
| Activity | Comércio de produtos farmacêuticos. perfumaria e afins. |
| Share | RADL3 |
| Quote Date | 11/19/2024 |
| Share Type | ON |
| Last Closing | R$ 25.78 |
| Quotation Factor | 1 Share |
| Financial Volume | R$ 83.78 M |
| Last Statement | ITR - 09/30/2024 |
| Sector | Saúde |
| Subsector | Comércio e Distribuição |
| Segment | Medicamentos e Outros Produtos |
| Participation Indexes | GPTW, IBOVESPA, IBRA, IBRX, IBRX50, ICO2, ICON, IGC, IGCT, IGNM, ISE, ITAG, IVBX, MLCX |
| Updated 11/21/2024 |
Relative Prices, Market Cap, EV, and Dividend Yield | |
|---|
| Price/Earnings | 39.89 |
| Price/SBV | 7.03 |
| Price/Net Sales | 1.17 |
| Price/CFO | 18.77 |
| Price/FCF | 39.79 |
| Price/Total Assets | 2.02 |
| Price/EBIT | 18.97 |
| Price/Working Capital | 12.33 |
| Price/NCAV | -3.67 |
| EV/EBIT | 20.19 |
| EV/EBITDA | 11.40 |
| EV/Net Sales | 1.25 |
| EV/CFO | 19.98 |
| EV/FCF | 42.36 |
| EV/Total Assets | 2.15 |
| Company Market Cap | R$ 44.29 B |
| Enterprise Value | R$ 47.15 B |
| Current Financial Statement Date | 09/30/2024 |
| Current Share Price | R$ 25.78 |
| Share Price Date | 11/19/2024 |
| Dividend Yield | 1.42% |
Summary Income Statement Last 12 Months | |
|---|
| Net Revenue | R$ 37.70 B |
| Gross Result | R$ 11.25 B |
| EBIT | R$ 2.34 B |
| Depreciation and Amortization | - R$ 1.80 B |
| EBITDA | R$ 4.14 B |
| Net Profit | R$ 1.11 B |
| Net Profit/Share | R$ 0.65 |
Summary Income Statement Last Quarter | |
|---|
| Net Revenue | R$ 9.99 B |
| Gross Result | R$ 2.97 B |
| EBIT | R$ 679.00 M |
| Depreciation and Amortization | - R$ 501.91 M |
| EBITDA | R$ 1.18 B |
| Net Profit | R$ 335.02 M |
| Profit/Share | R$ 0.20 |
Stock Price and Stock Volume Behavior| Lowest Price 52 weeks | R$ 23.98 |
| Highest Price 52 weeks | R$ 29.92 |
| Variation 2024 | -10.82% |
| Variation 1 year | -8.60% |
| Variation 2 years(total) | 18.37% |
| Variation 2 years(yearly) | 8.77% |
| Variation 3 years(total) | 18.96% |
| Variation 3 years(yearly) | 5.95% |
| Variation 4 years(total) | 5.07% |
| Variation 4 years(yearly) | 1.24% |
| Variation 5 years(total) | 25.98% |
| Variation 5 years(yearly) | 4.72% |
| Average Daily Volume (3 months) | R$ 157.72 M |
| Updated 11/21/2024 |
Returns, Margins, and Other Measures | |
|---|
| Return on Initial Tangible Capital | 15.73% |
| Return on Initial Invested Capital | 18.72% |
| Pre-Tax Return on Initial Tangible Capital | 23.84% |
| Pre-Tax Return on Initial Invested Capital | 28.37% |
| Return on Initial Shareholder´s Equity | 19.40% |
| Return on Initial Asset | 5.73% |
| Gross Margin | 29.83% |
| Net Margin | 2.95% |
| EBIT Margin | 6.19% |
| EBITDA Margin | 10.97% |
| Initial Asset Turnover | 1.94 |
| Financial Leverage | 3.48 |
| Liabilities/Net Worth | 2.48 |
| Net Debt/EBITDA | 0.69 |
Summary Balance Sheet | |
|---|
| Cash and Cash Equivalents | R$ 410.51 M |
| Total Assets | R$ 21.96 B |
| Short-Term Debt | R$ 619.04 M |
| Long-Term Debt | R$ 2.66 B |
| Gross Debt | R$ 3.27 B |
| Net Debt | R$ 2.86 B |
| Shareholder´s Equity | R$ 6.30 B |
| Share Book Value | R$ 3.67 |
| Common Shares | 1,718,007,200 |
| Preferred Shares | 0 |
| Total | 1,718,007,200 |
| Common Shares in Treasury | 2,880,891 |
| Preferred Shares in Treasury | 0 |
| Total in Treasury | 2,880,891 |
| Common Shares (Except Treasury) | 1,715,126,309 |
| Preferred Shares (Except Treasury) | 0 |
| Total (Except Treasury) | 1,715,126,309 |
Summary Cash Flow Statement Last 12 Months | |
|---|
| Operating Cash Flow | R$ 2.36 B |
| Cash Flow from Investments | - R$ 1.25 B |
| Financing Cash Flow | - R$ 1.30 B |
| Increase (Reduction) in Cash and Equivalents | - R$ 183.08 M |
Summary Cash Flow Statement Last Quarter | |
|---|
| Operating Cash Flow | R$ 777.10 M |
| Cash Flow from Investments | - R$ 369.19 M |
| Financing Cash Flow | - R$ 367.06 M |
| Increase (Reduction) in Cash and Equivalents | R$ 40.85 M |
Experimental CAPEX and Free Cash Flow Calculation | |
|---|
| CAPEX 3 months | - R$ 369.19 M |
| Free Cash Flow 3 months | R$ 407.91 M |
| CAPEX 12 months | - R$ 1.25 B |
| Free Cash Flow 12 months | R$ 1.11 B |